AHA urges FCC to extend COVID-19 program to all direct care facilities

May 08, 2020 - 03:17 PM
oig-telehealth

AHA yesterday urged the Federal Communications Commission to grant expedited approval to its request that the agency extend the COVID-19 Telehealth Program to all hospitals and other direct patient care facilities, regardless of their size, location, or for-profit or not-for-profit status.

"Members of the health care community have already responded to Commissioner Carr's request for input and have strongly supported AHA's Petition," the association wrote. "Communities across the nation rely on all of America's health care providers (HCPs) to be there for them in times of emergencies. ... While the health care community is doing everything it can under extremely difficult circumstances, more financial support must be provided to HCPs across the board if they are to fully leverage telehealth in their efforts to stem the staggering toll of the virus while maintaining access to care for non-COVID patients."

Related News Articles

Headline
CDC releases 2025-26 respiratory disease season outlook
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…
Headline
OSHA extends comment period on proposal removing remaining COVID-19 emergency temporary standard requirements
The Occupational Safety and Health Administration today announced a 60-day extension of the comment period on its proposed rule to remove the remaining…
Headline
CDC says COVID-19 cases growing or likely growing in 45 states 
COVID-19 infections are growing or likely growing in 45 states and not changing in five states, according to the latest data from the Centers for Disease…
Chairperson's File
Chair File: The OBBBA and What’s Next for Health Care
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…